IRIS
BONI, CAROLINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.737
AS - Asia 3.003
EU - Europa 1.726
SA - Sud America 443
AF - Africa 163
Continente sconosciuto - Info sul continente non disponibili 125
OC - Oceania 13
Totale 9.210
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.581
SG - Singapore 965
CN - Cina 660
IT - Italia 591
VN - Vietnam 553
BR - Brasile 344
IE - Irlanda 235
HK - Hong Kong 227
BD - Bangladesh 208
DE - Germania 194
SE - Svezia 183
FR - Francia 128
ZA - Sudafrica 104
CA - Canada 91
TR - Turchia 87
NL - Olanda 81
FI - Finlandia 74
IN - India 64
GB - Regno Unito 54
RU - Federazione Russa 46
KR - Corea 35
AR - Argentina 34
JP - Giappone 32
MX - Messico 26
IQ - Iraq 22
CI - Costa d'Avorio 18
PH - Filippine 18
AT - Austria 17
CO - Colombia 17
ID - Indonesia 17
PK - Pakistan 16
UA - Ucraina 14
UZ - Uzbekistan 14
BE - Belgio 13
EC - Ecuador 13
AU - Australia 12
CR - Costa Rica 12
LT - Lituania 12
DK - Danimarca 11
MA - Marocco 11
TH - Thailandia 11
TW - Taiwan 11
VE - Venezuela 11
ES - Italia 10
PL - Polonia 10
SA - Arabia Saudita 10
KE - Kenya 9
CZ - Repubblica Ceca 8
MY - Malesia 8
PY - Paraguay 7
AE - Emirati Arabi Uniti 6
CH - Svizzera 6
BG - Bulgaria 5
EG - Egitto 5
IR - Iran 5
JM - Giamaica 5
RO - Romania 5
UY - Uruguay 5
AL - Albania 4
AZ - Azerbaigian 4
CL - Cile 4
HN - Honduras 4
IL - Israele 4
JO - Giordania 4
LV - Lettonia 4
NI - Nicaragua 4
PE - Perù 4
PT - Portogallo 4
TN - Tunisia 4
BO - Bolivia 3
GE - Georgia 3
GT - Guatemala 3
BS - Bahamas 2
DZ - Algeria 2
EE - Estonia 2
ET - Etiopia 2
GP - Guadalupe 2
GR - Grecia 2
KG - Kirghizistan 2
KH - Cambogia 2
KZ - Kazakistan 2
LU - Lussemburgo 2
NG - Nigeria 2
NP - Nepal 2
OM - Oman 2
PA - Panama 2
PS - Palestinian Territory 2
RS - Serbia 2
SV - El Salvador 2
TZ - Tanzania 2
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BH - Bahrain 1
BY - Bielorussia 1
CM - Camerun 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DO - Repubblica Dominicana 1
HR - Croazia 1
Totale 9.070
Salva come PNG Salva come JPEG
Città #
Ashburn 503
Singapore 493
Dallas 418
San Jose 400
Santa Clara 344
Dublin 234
Hong Kong 211
Chandler 177
Ho Chi Minh City 154
Parma 148
Beijing 143
Hanoi 140
Council Bluffs 124
New York 123
Boardman 113
Johannesburg 95
Los Angeles 86
Munich 85
Dearborn 79
Milan 72
Shanghai 71
Izmir 65
Ann Arbor 55
Lauterbourg 51
Buffalo 42
Chicago 38
São Paulo 38
Hefei 34
Nanjing 34
Princeton 34
Haiphong 32
Wilmington 32
Bologna 30
Rome 28
Toronto 28
Turku 28
Columbus 27
Frankfurt am Main 26
Montreal 24
Moscow 23
Da Nang 22
Tokyo 22
Rio de Janeiro 19
Abidjan 18
Houston 18
Phoenix 18
Shenyang 18
The Dalles 18
Nuremberg 17
Reggio Emilia 16
Guangzhou 15
Seattle 15
Seoul 15
Grafing 14
Helsinki 14
Hải Dương 14
London 14
Nanchang 14
Brussels 13
Hebei 13
Jacksonville 13
Tashkent 13
Baghdad 11
Bremen 11
Changsha 11
Naples 11
Orem 11
San Francisco 11
Vienna 11
Brooklyn 10
Curitiba 10
Denver 10
Düsseldorf 10
Stockholm 10
Bengaluru 9
Can Tho 9
Jakarta 9
Limena 9
San Antonio 9
Hangzhou 8
Modena 8
Montespertoli 8
Nairobi 8
Taastrup 8
Tianjin 8
Warsaw 8
Zhengzhou 8
Atlanta 7
Bangkok 7
Boston 7
Chennai 7
Istanbul 7
Jinan 7
Mexico City 7
Norwalk 7
Ottawa 7
Biên Hòa 6
Brescia 6
Charlotte 6
Dhaka 6
Totale 5.558
Salva come PNG Salva come JPEG
Nome #
FUNCTIONAL AND TRANSCRIPTIONAL RESTORATION OF EXHAUSTED VIRUS-SPECIFIC T LYMPHOCYTES FROM PATIENTS WITH CHRONIC HEPATITIS B 344
A novel enhancing effect of SARS-CoV-2 mutations on anti-viral CD8 T cell responses 329
Targeting mitochondrial dysfunction can restore antiviral activity of exhausted HBV-specific CD8 T cells in chronic hepatitis B 298
Targeting p53 and histone methyltransferases restores exhausted CD8+ T cells in HCV infection 294
HBcrAg values may predict virological and immunological responses to pegIFN-α in NUC-suppressed HBeAg-negative chronic hepatitis B 268
A holistic evaluation of patients with chronic Hepatitis D virus (HDV) infection enrolled in the Italian PITER-B and delta cohort 219
TLR7 Agonist Increases Responses of Hepatitis B Virus–Specific T Cells and Natural Killer Cells in Patients With Chronic Hepatitis B Treated With Nucleos(T)Ide Analogues 218
Therapeutic potential of co-signaling receptor modulation in hepatitis B 208
Deregulated intracellular pathways define novel molecular targets for HBV-specific CD8 T cell reconstitution in chronic hepatitis B 199
Natural heteroclitic-like peptides are generated by SARS-CoV-2 mutations 198
Pathogenetic Mechanisms of T Cell Dysfunction in Chronic HBV Infection and Related Therapeutic Approaches 197
Metabolic regulation of the HBV-specific T cell function 187
Direct ex vivo analysis of hepatitis B virus-specific CD8(+) T cells associated with the control of infection 172
Combined GS-4774 and Tenofovir Therapy Can Improve HBV-Specific T-Cell Responses in Patients With Chronic Hepatitis 169
Acute phase HBV-specific T cell responses associated with HBV persistence after HBV/HCV coinfection 163
Natural killer cell phenotype modulation and natural killer/T-cell interplay in nucleos(t)ide analogue-treated hepatitis e antigen-negative patients with chronic hepatitis B 163
PeptiVAX: A new adaptable peptides-delivery platform for development of CTL-based, SARS-CoV-2 vaccines 161
Degenerate CD8 Epitopes Mapping to Structurally Constrained Regions of the Spike Protein: A T Cell-Based Way-Out From the SARS-CoV-2 Variants Storm 160
Antiviral CD8-mediated responses in chronic HCV carriers with HBV superinfection 157
HBV immune-therapy: From molecular mechanisms to clinical applications 157
The good and the bad of natural killer cells in virus control: Perspective for anti-HBV therapy 154
T cell regulation in HBV-related chronic liver disease 154
Phenotypic CD8 T cell profiling in chronic hepatitis B to predict HBV-specific CD8 T cell susceptibility to functional restoration in vitro 152
Antigen Load and T Cell Function: A Challenging Interaction in HBV Infection 151
Targeting Stress Sensor Kinases in Hepatocellular Carcinoma-Infiltrating Human NK Cells as a Novel Immunotherapeutic Strategy for Liver Cancer 146
Unraveling the multifaceted nature of cd8 t cell exhaustion provides the molecular basis for therapeutic t cell reconstitution in chronic hepatitis b and c 144
Early kinetics of innate and adaptive immune responses during hepatitis B virus infection 142
What Is the Current Status of Hepatitis B Virus Viro-Immunology? 141
Increased levels of arginase in patients with acute hepatitis B suppress antiviral T cells 130
Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection 130
FluoroSpot assay to analyze SARS-CoV-2-specific T cell responses 130
Functional reconstitution of HBV-specific CD8 T cells by in vitro polyphenol treatment in chronic hepatitis B 127
Identification of immunodominant hepatitis C virus (HCV)-specific cytotoxic T-cell epitopes by stimulation with endogenously synthesized HCV antigens 126
The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection 125
Contribution of herpesvirus specific CD8 T cells to anti-viral T cell response in humans 124
Strategies to overcome HBV-specific T cell exhaustion: checkpoint inhibitors and metabolic re-programming 123
Conserved hepatitis C virus sequences are highly immunogenic for CD4+ T cells: Implications for vaccine development 121
Virus-specific CD8+ lymphocytes share the same effector-memory phenotype but exhibit functional differences in acute hepatitis B and C 117
Comment on ‘End-of-treatment HBcrAg and HBsAb levels identify durable functional cure after Peg-IFN-based therapy in patients with CHB’ 114
High CD49a+ NK cell infiltrate is associated with poor clinical outcomes in Hepatocellular Carcinoma 113
Mobilizing monocytes to cross-present circulating viral antigen in chronic infection 113
Comparative pathogenesis of HBV and HCV 113
Antiviral cell-mediated immune responses during hepatitis B and hepatitis C virus infections 112
Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B 111
Effector CD8(+) T cell-derived interleukin-10 enhances acute liver immunopathology 110
The Characteristics of the Cell-Mediated Immune Response Identify Different Profiles of Occult Hepatitis B Virus Infection 107
The scientific basis of combination therapy for chronic hepatitis B functional cure 106
Different cytokine profiles of intrahepatic T cells in chronic hepatitis B and hepatitis C virus infections 105
Predominant T-helper 1 cytokine profile of hepatitis B virus nucleocapsid-specific T cells in acute self-limited hepatitis B 103
Editorial: Epigenetic and metabolic regulation of immunity during infection or cancer and associated immune biomarkers 100
Restored function of HBV-specific T cells after long-term effective therapy with nucleos(t)ide analogues 99
Hepatitis B virus specific immune response: From antigen recognition to liver damage 98
Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: New perspectives for immune therapy 97
TGF-β-driven NK Cells plasticity in hepatocellular carcinoma 96
Transient restoration of anti-viral T cell responses induced by lamivudine therapy in chronic hepatitis B 94
Molecular features of the hepatitis B virus nucleocapsid T-cell epitope 18-27: interaction with HLA and T-cell receptor 93
T and NK Cell-Based Immunotherapy in Chronic Viral Hepatitis and Hepatocellular Carcinoma 90
Immunopathogenesis of hepatitis C virus infection 84
T cell receptor usage of virus-specific CD8 cells and recognition of viral mutations during acute and persistent hepatitis B virus infection 81
Transcriptional and functional HBV-specific CD8 T cell changes from disease to functional cure in HBeAg-negative chronic hepatitis B 76
Host ethnicity and virus genotype shape the hepatitis B virus-specific T-cell repertoire 70
Immunopathogenesis of hepatitis B 66
HBV antigens quantity: duration and effect on functional cure 62
Dysregulated transcription in core- and pol-specific CD8 T cells can be targeted by HDAC inhibition to improve T-cell function in chronic hepatitis B 38
Sex-based differences in hepatitis delta virus infection: Insights from the Italian PITER hepatitis delta virus cohort 33
Temporal transcriptional dynamics in HBV-specific CD8 T cells during long-term NUC therapy in HBeAg- chronic hepatitis B 28
Totale 9.210
Salva come PNG Salva come JPEG
Categoria #
all - tutte 32.786
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.786
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022183 0 0 0 26 20 21 11 13 13 4 11 64
2022/2023771 82 66 42 49 58 78 15 40 258 6 40 37
2023/2024548 27 49 27 52 31 119 56 28 25 35 37 62
2024/20251.912 63 91 102 127 200 234 110 127 232 136 163 327
2025/20264.197 348 568 390 296 470 210 405 138 601 303 211 257
2026/2027930 141 199 227 363 0 0 0 0 0 0 0 0
Totale 9.210